Chiara Barattieri di San Pietro

Dr. Chiara Barattieri di San Pietro

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2019 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
OCon behalf of the RADAR-CNS consortium
on behalf of the RADAR-CNS consortium
FMF. Matcham
F. Matcham
CPChiara Barattieri di San Pietro
Chiara Barattieri di San Pietro
VBV. Bulgari
V. Bulgari
GGG. de Girolamo
G. de Girolamo
MHM. Hotopf
M. Hotopf
There is a growing body of literature highlighting the role that wearable and mobile remote measurement technology (RMT) can play in measuring symptoms of major depressive disorder (MDD). Outcomes assessment typically relies on self-report, which can be biased by dysfunctional perceptions and current symptom severity. Predictors of depressive relapse include disrupted sleep, reduced sociability, physical activity, changes in mood, prosody and cognitive function, which are all amenable to measurement via RMT. This study aims to: 1) determine the usability, feasibility and acceptability of RMT; 2) improve and refine clinical outcome measurement using RMT to identify current clinical state; 3) determine whether RMT can provide information predictive of depressive relapse and other critical outcomes. RADAR-MDD is a multi-site prospective cohort study, aiming to recruit 600 participants with a history of depressive disorder across three sites: London, Amsterdam and Barcelona. Participants will be asked to wear a wrist-worn activity tracker and download several apps onto their smartphones. These apps will be used to either collect data passively from existing smartphone sensors, or to deliver questionnaires, cognitive tasks, and speech assessments. The wearable device, smartphone sensors and questionnaires will collect data for up to 2-years about participants’ sleep, physical activity, stress, mood, sociability, speech patterns, and cognitive function. The primary outcome of interest is MDD relapse, defined via the Inventory of Depressive Symptomatology- Self-Report questionnaire (IDS-SR) and the World Health Organisation’s self-reported Composite International Diagnostic Interview (CIDI-SF). This study aims to provide insight into the early predictors of major depressive relapse, measured unobtrusively via RMT. If found to be acceptable to patients and other key stakeholders and able to provide clinically useful information predictive of future deterioration, RMT has potential to change the way in which depression and other long-term conditions are measured and managed.

30 January 2019 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
SSSara Simblett
Sara Simblett
FMFaith Matcham
Faith Matcham
SSSara Siddi
Sara Siddi
VBViola Bulgari
Viola Bulgari
CPChiara Barattieri di San Pietro
Chiara Barattieri di San Pietro
RCRADAR-CNS Consortium
RADAR-CNS Consortium
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Mobile technology has the potential to provide more accurate, impactful data on the symptoms of depression, which could improve health management or even assist in early detection of relapse. However, for this potential to be achieved, it is essential that patients engage with the technology. While many barriers and facilitators are common across therapeutic areas and technology types, many may be culture and health context-specific. Objective: This study was designed to understand potential barriers and facilitators to engagement with mobile health (mHealth) technology for remote measurement and management of depression across three Western European countries. Methods: Participants with experience of depression took part in five focus groups held in three countries (2 in the UK, 2 in Spain, and 1 in Italy) investigating potential barriers and facilitators to the use of mHealth technology. A systematic thematic analysis was used to extract themes and subthemes. Results: Facilitators and barriers were organised as: (1) health-related factors; (2) user-related factors; and (3) technology-related factors. Fifty-eight subthemes of specific barriers and facilitators or moderators emerged. A core group of themes including motivation, potential impact on mood and anxiety, aspects of inconvenience and ease of use were present across all countries. Conclusions: Similarities in the barriers and facilitators to use of mHealth technology have been found across Spain, Italy, and the UK. These themes provide guidance on ways to promote the design of feasible and acceptable cross-cultural mHealth tools.

12 November 2009 in Future Neurology
Verified
Journal Article
Closed access
ARAlberto Redolfi
Alberto Redolfi
RMRichard McClatchey
Richard McClatchey
AAAshiq Anjum
Ashiq Anjum
AZAlex Zijdenbos
Alex Zijdenbos
DMDavid Manset
David Manset
GFGiovanni B. Frisoni
Giovanni B. Frisoni
Neuroscience is increasingly making use of statistical and mathematical tools to extract information from images of biological tissues. Computational neuroimaging tools require substantial computational resources and the increasing availability of large image datasets will further enhance this need. Many efforts have been directed towards creating brain image repositories including the recent US Alzheimer Disease Neuroimaging Initiative. Multisite-distributed computing infrastructures have been launched with the goal of fostering shared resources and facilitating data analysis in the study of neurodegenerative diseases. Currently, some Grid- and non-Grid-based projects are aiming to establish distributed e-infrastructures, interconnecting compatible imaging datasets and to supply neuroscientists with the most advanced information and communication technologies tools to study markers of Alzheimer’s and other brain diseases, but they have so far failed to make a difference in the larger neuroscience communi...

1 September 2019 in Journal of Psychosomatic Research
Verified
Journal Article
Closed access
ARAki Rintala
Aki Rintala
FMF. Matcham
F. Matcham
MRM. Radaelli
M. Radaelli
GLG. Locafaro
G. Locafaro
SSS. Simblett
S. Simblett
IMI. Myin-Germeys
I. Myin-Germeys

27 April 2020 in Depression and Anxiety
Verified
Journal Article
Closed access
PDF file
GGGiovanni Girolamo
Giovanni Girolamo
CPChiara Barattieri di San Pietro
Chiara Barattieri di San Pietro
VBViola Bulgari
Viola Bulgari
JDJessica Dagani
Jessica Dagani
CFClarissa Ferrari
Clarissa Ferrari
TCthe RADAR‐CNS Consortium
the RADAR‐CNS Consortium

16 April 2025 in JMIR Formative Research
Verified
Journal Article
Open access
Cristina CrocamoCristina Crocamo
Cristina Crocamo
RCRiccardo Matteo Cioni
Riccardo Matteo Cioni
ACAurelia Canestro
Aurelia Canestro
CNChristian Nasti
Christian Nasti
DPDario Palpella
Dario Palpella
GCGiuseppe Carrà
Giuseppe Carrà
Background: Monitoring symptoms of bipolar disorder (BD) is a challenge faced by mental health services. Speech patterns are crucial in assessing the current experiences, emotions, and thought patterns of people with BD. Natural language processing (NLP) and acoustic signal processing may support ongoing BD assessment within a mobile health (mHealth) framework. Objective: Using both acoustic and NLP-based features from the speech of people with BD, we built an app-based tool and tested its feasibility and performance to remotely assess the individual clinical status. Methods: We carried out a pilot, observational study, sampling adults diagnosed with BD from the caseload of the Nord Milano Mental Health Trust (Italy) to explore the relationship between selected speech features and symptom severity and to test their potential to remotely assess mental health status. Symptom severity assessment was based on clinician ratings, using the Young Mania Rating Scale (YMRS) and Montgomery-Åsberg Depression Rating Scale (MADRS) for manic and depressive symptoms, respectively. Leveraging a digital health tool embedded in a mobile app, which records and processes speech, participants self-administered verbal performance tasks. Both NLP-based and acoustic features were extracted, testing associations with mood states and exploiting machine learning approaches based on random forest models. Results: We included 32 subjects (mean [SD] age 49.6 [14.3] years; 50% [16/32] females) with a MADRS median (IQR) score of 13 (21) and a YMRS median (IQR) score of 5 (16). Participants freely managed the digital environment of the app, without perceiving it as intrusive and reporting an acceptable system usability level (average score 73.5, SD 19.7). Small-to-moderate correlations between speech features and symptom severity were uncovered, with sex-based differences in predictive capability. Higher latency time (ρ=0.152), increased silences (ρ=0.416), and vocal perturbations correlated with depressive symptomatology. Pressure of speech based on the mean intraword time (ρ=–0.343) and lower voice instability based on jitter-related parameters (ρ ranging from –0.19 to –0.27) were detected for manic symptoms. However, a higher contribution of NLP-based and conversational features, rather than acoustic features, was uncovered, especially for predictive models for depressive symptom severity (NLP-based: R2=0.25, mean squared error [MSE]=110.07, mean absolute error [MAE]=8.17; acoustics: R2=0.11, MSE=133.75, MAE=8.86; combined: R2=0.16; MSE=118.53, MAE=8.68). Conclusions: Remotely collected speech patterns, including both linguistic and acoustic features, are associated with symptom severity levels and may help differentiate clinical conditions in individuals with BD during their mood state assessments. In the future, multimodal, smartphone-integrated digital ecological momentary assessments could serve as a powerful tool for clinical purposes, remotely complementing standard, in-person mental health evaluations.